{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:26:55Z","timestamp":1793730415318,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.imbio.2026.153230","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:07:01Z","timestamp":1786201621000},"page":"153230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation and evaluation of anti-SARS-CoV-2 RBD-S chicken IgY antibodies for passive immunisation research"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7388-2724","authenticated-orcid":false,"given":"Dhruvi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-4405","authenticated-orcid":false,"given":"K.","family":"Gireesh Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7711-8306","authenticated-orcid":false,"given":"Ronak","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7339-5715","authenticated-orcid":false,"given":"Sreenivasa","family":"Nayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-0888","authenticated-orcid":false,"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-8016","authenticated-orcid":false,"given":"Apurva","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-9317","authenticated-orcid":false,"given":"Rozidaini Mohd","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/21645515.2018.1514224","article-title":"IgY antibodies for the immunoprophylaxis and therapy of respiratory infections","volume":"15","author":"Abbas","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.imbio.2026.153230_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118054","article-title":"Tackling the cytokine storm in COVID-19, challenges and hopes","volume":"257","author":"Abdin","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.imbio.2026.153230_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12195-020-00664-7","article-title":"Engineered aptamers for enhanced COVID-19 theranostics","volume":"14","author":"Acquah","year":"2021","journal-title":"Cell. Mol. Bioeng."},{"issue":"3","key":"10.1016\/j.imbio.2026.153230_bb0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jgeb.2017.10.003","article-title":"Production and purification of IgY antibodies from chicken egg yolk","volume":"16","author":"Amro","year":"2018","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153230_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252399","article-title":"Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication","volume":"16","author":"Artman","year":"2021","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.imbio.2026.153230_bb0035","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jmv.26417","article-title":"Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America","volume":"93","author":"Banerjee","year":"2021","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153230_bb0040","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/jam.15340","article-title":"Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker","volume":"132","author":"Bao","year":"2022","journal-title":"J. Appl. Microbiol."},{"issue":"7","key":"10.1016\/j.imbio.2026.153230_bb0045","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v13071292","article-title":"Potential prophylactic treatments for COVID-19","volume":"13","author":"Ben-Zuk","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3892\/etm.2020.8704","article-title":"IgY-turning the page toward passive immunization in COVID-19 infection","volume":"20","author":"Constantin","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.imbio.2026.153230_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09540100120094537","article-title":"Isolation and purification of chicken egg yolk immunoglobulins: a review","volume":"13","author":"De Meulenaer","year":"2001","journal-title":"Food Agric. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2026.153230_bb0060","first-page":"1631","article-title":"A new threat from an old enemy: re-emergence of coronavirus","volume":"45","author":"Docea","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"17","key":"10.1016\/j.imbio.2026.153230_bb0065","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.imbio.2026.153230_bb0070","first-page":"179","article-title":"An ELISA for the quantification of chicken immunoglobulin (IgY) in various liquid media","volume":"13","author":"Fischer","year":"1996","journal-title":"ALTEX-Altern. Anim. Exp"},{"key":"10.1016\/j.imbio.2026.153230_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10238-020-00671-y","article-title":"Emerging treatment strategies for COVID-19 infection","volume":"21","author":"Gavriatopoulou","year":"2021","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaci.2020.04.043","article-title":"Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients\u2014a perspective","volume":"146","author":"Hammarstr\u00f6m","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2026.153230_bb0085","doi-asserted-by":"crossref","unstructured":"He, F., 2011. Laemmli-sds-page. Bio-protocol. 1 (11). 10.21769\/BioProtoc.80.","DOI":"10.21769\/BioProtoc.80"},{"key":"10.1016\/j.imbio.2026.153230_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.561264","article-title":"Clinical symptom differences between mild and severe COVID-19 patients in China: a meta-analysis","volume":"8","author":"He","year":"2021","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0095","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1038\/s41467-021-25480-z","article-title":"A potent SARS-CoV-2 neutralizing nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19","volume":"12","author":"Huo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2026.153230_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105254","article-title":"Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage","volume":"99","author":"Kirtipal","year":"2022","journal-title":"Infect. Genet. Evol."},{"issue":"4","key":"10.1016\/j.imbio.2026.153230_bb0105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"5259","key":"10.1016\/j.imbio.2026.153230_bb0110","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","article-title":"Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis","volume":"203","author":"Lim","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9465398","article-title":"Generation of chicken IgY against SARS-COV-2 spike protein and epitope mapping","volume":"2020","author":"Lu","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.imbio.2026.153230_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107797","article-title":"The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-\u03b3 production in vitro","volume":"96","author":"Lyu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imbio.2026.153230_bb0130","article-title":"Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials","volume":"2","author":"Martins-Filho","year":"2021","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.imbio.2026.153230_bb0135","article-title":"Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge","volume":"183","author":"O\u2019Donnell","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.imbio.2026.153230_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2025.110928","article-title":"Comprehensive analysis of the major IgY antibody extraction strategies from chicken egg yolk","volume":"283","author":"Patel","year":"2025","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.imbio.2026.153230_bb0145","article-title":"IgY technology: extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation","volume":"51","author":"Pauly","year":"2011","journal-title":"JoVE (J. Vis. Exp.)"},{"key":"10.1016\/j.imbio.2026.153230_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.intimp.2019.05.015","article-title":"Egg yolk antibodies (IgY) and their applications in human and veterinary health: a review","volume":"73","author":"Pereira","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153230_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030486","article-title":"Can immunization of hens provide oral-based therapeutics against COVID-19?","volume":"8","author":"P\u00e9rez de la Lastra","year":"2020","journal-title":"Vaccines"},{"issue":"7852","key":"10.1016\/j.imbio.2026.153230_bb0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.imbio.2026.153230_bb0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/08820138009066010","article-title":"Isolation of viral IgY antibodies from yolks of immunized hens","volume":"9","author":"Polson","year":"1980","journal-title":"Immunol. Commun."},{"issue":"2","key":"10.1016\/j.imbio.2026.153230_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pathogens9020148","article-title":"Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development","volume":"9","author":"Shanmugaraj","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.imbio.2026.153230_bb0175","first-page":"1","article-title":"Anti-SARS-CoV-2 IgY isolated from egg yolks of hens immunized with inactivated SARS-CoV-2 for immunoprophylaxis of COVID-19","author":"Shen","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.imbio.2026.153230_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.imbio.2026.153230_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106654","article-title":"An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: a review","volume":"85","author":"Somasundaram","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153230_bb0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08820139009041840","article-title":"Isolation of IgY from the yolks of eggs by a chloroform polyethylene glycol procedure","volume":"19","author":"Son","year":"1990","journal-title":"Immunol. Investig."},{"issue":"5","key":"10.1016\/j.imbio.2026.153230_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biologicals.2012.05.003","article-title":"Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy","volume":"40","author":"Spillner","year":"2012","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.imbio.2026.153230_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3892\/etm.2020.8692","article-title":"Treatment strategies to fight the new coronavirus SARS-CoV-2: a challenge for a Rubik\u2019s Cube solver","volume":"20","author":"Tsitoura","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.imbio.2026.153230_bb0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3892\/mmr.2011.410","article-title":"Antibodies against swine influenza virus neutralize the pandemic influenza virus A\/H1N1","volume":"4","author":"Tsukamoto","year":"2011","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.imbio.2026.153230_bb0215","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/CVI.05075-11","article-title":"Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice","volume":"18","author":"Wallach","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153230_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2026.153230_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107172","article-title":"Chicken egg yolk antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2","volume":"90","author":"Wei","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/vaccines10010128","article-title":"Preclinical evaluation of chicken egg yolk antibody (IgY) anti-RBD spike SARS-CoV-2\u2014a candidate for passive immunization against COVID-19","volume":"10","author":"Wongso","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.imbio.2026.153230_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-021-00523-5","article-title":"SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.imbio.2026.153230_bb0240","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1080\/09168451.2016.1217144","article-title":"Preparation of chicken IgY against recombinant E2 protein of bovine viral diarrhea virus (BVDV) and development of ELISA and ICA for BVDV detection","volume":"80","author":"Zhang","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"4","key":"10.1016\/j.imbio.2026.153230_bb0245","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/brv.12325","article-title":"IgY: a key isotype in antibody evolution","volume":"92","author":"Zhang","year":"2017","journal-title":"Biol. Rev."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:32:32Z","timestamp":1793727152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0171298526000768"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153230","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and evaluation of anti-SARS-CoV-2 RBD-S chicken IgY antibodies for passive immunisation research","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153230"}}